Professor, Fox Chase Cancer Center
Co-Leader, Blood Cell Development and Cancer Keystone, Fox Chase Cancer Center
Director, DNA Sequencing Facility, Fox Chase Cancer Center
Director, Cell Sorting Facility, Fox Chase Cancer Center
EDUCATION AND BACKGROUND:
Dr Hardy earned his BS in chemistry from the Illinois Institute of Technology and his PhD, in biochemistry from the California Institute of Technology, where he received the Herbert Newby McCoy Award for outstanding achievement in research. He completed his postdoctoral training at Stanford University, where he was a fellow of the California Division of the American Cancer Society. He was a visiting scientist at Osaka Universitys Institute for Cellular and Molecular Biology in Japan for two years before joining Fox Chase in 1987.
Dr Hardys research interests include development of the immune systems B lymphocytes from stem cells in fetal liver and bone marrow; regulation of this process by pre-B-cell receptors; and the development and function of B-cell subsets, including the early generated B-1 B cells and their role in autoimmunity, leukemia and chronic B-cell lymphoma. These B1 B-cells predominate during prenatal and newborn development but dwindle to a small minority in adults. This unusual cell type holds special interest because of its tendency to grow out of control and its association with hematologic cancers. Hardys research includes study of B-1 cell genes and antibody targets to help reveal the genetic origin of related cancers and to increase understanding of their role in malignancies.
In the role of Faculty Member, Richard Hardy contributes recommendations and reviews to the Leukocyte Development Section in the Immunology Faculty, writing brief accessible comments to summarize the value of the articles and adding rating score.
The Faculty comprises Heads of Faculty, Heads of Section, Faculty Members and Associate Faculty Members, as well as an International Advisory Board.
Read more about F1000Prime »